Literature DB >> 24124847

Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib.

Alexander Jack1, Michael J Mauro2, Benjamin D Ehst3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24124847     DOI： 10.1016/j.jaad.2013.04.061

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

Review 1.  Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review.

Authors:  Maria Vastarella; Gabriella Fabbrocini; Vincent Sibaud
Journal:  Drug Saf       Date:  2020-05       Impact factor: 5.606

2.  Ichthyosiform Pityriasis Rubra Pilaris-Like Eruption Secondary to Ponatinib Therapy: Case Report and Literature Review.

Authors:  Ariel E Eber; Alyx Rosen; Kate E Oberlin; Alessio Giubellino; Paolo Romanelli
Journal:  Drug Saf Case Rep       Date:  2017-11-14

3.  A patient with maculopapular rash and lichenoid skin damage caused by ponatinib.

Authors:  Ingrid Anna Teigen; Anna Kristine Myrmel Sæle; Håkon Reikvam
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.